For instance, the presence of anti-Jo-1 antibodies can guide clinicians to look for interstitial lung disease and initiate early treatment. Similarly, recognizing anti-TIF1- antibodies in a ...

On March 13, 2006, eight healthy male volunteers participated in a double-blind, randomized, placebo-controlled phase 1 study of the safety of TGN1412 (TeGenero), a novel monoclonal antibody. The ...

Antibodies that attack ... the result is a “true positive” result, meaning you have significant ANAs and an autoimmune disease. For example, for a ratio of 1:40 or 1:80, the possibility ...